Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 307 entries
Sorted by: Best Match Show Resources per page
Normalizing the Racial Divide in High School Computer Science

Science and underrepresentation

Holme JJ.
GSID: izOouoldH68J
J Margolis, R Estrella, J Goode, JJ Holme, K Nao - 2008 - ieeexplore.ieee.org

This chapter contains section titled: Westward Senior High School, No Opportunity to Learn Computer Science, Interest But No Place to Hang and Learn, Being Really, Really Smart to …

Cite
Margolis, J., Estrella, R., Goode, J., Holme, J. J., & Nao, K. (2008). Normalizing the Racial Divide in High School Computer Science.
Margolis, Jane, et al. "Normalizing the Racial Divide in High School Computer Science." (2008): 51-69.
Copy Download .nbib Format: MLA
Optical method for automated measurement of glass micropipette tip geometry.

Precision engineering

Stockslager MA, Capocasale CM, Holst GL, Simon MD, Li Y, McGruder DJ, Rousseau EB, Stoy WA, Sulchek T, Forest CR.
PMID: 27672230
Precis Eng. 2016 Oct;46:88-95. doi: 10.1016/j.precisioneng.2016.04.003. Epub 2016 Apr 02.

Many experimental biological techniques utilize hollow glass needles called micropipettes to perform fluid extraction, cell manipulation, and electrophysiological recordings For electrophysiological recordings, micropipettes are typically fabricated immediately before use using a "pipette puller", which uses open-loop control to heat...

Cite
Stockslager MA, Capocasale CM, Holst GL, et al. Optical method for automated measurement of glass micropipette tip geometry. Precis Eng. 2016;46:88-95doi: 10.1016/j.precisioneng.2016.04.003.
Stockslager, M. A., Capocasale, C. M., Holst, G. L., Simon, M. D., Li, Y., McGruder, D. J., Rousseau, E. B., Stoy, W. A., Sulchek, T., & Forest, C. R. (2016). Optical method for automated measurement of glass micropipette tip geometry. Precision engineering, 4688-95. https://doi.org/10.1016/j.precisioneng.2016.04.003
Stockslager, Max A, et al. "Optical method for automated measurement of glass micropipette tip geometry." Precision engineering vol. 46 (2016): 88-95. doi: https://doi.org/10.1016/j.precisioneng.2016.04.003
Stockslager MA, Capocasale CM, Holst GL, Simon MD, Li Y, McGruder DJ, Rousseau EB, Stoy WA, Sulchek T, Forest CR. Optical method for automated measurement of glass micropipette tip geometry. Precis Eng. 2016 Oct;46:88-95. doi: 10.1016/j.precisioneng.2016.04.003. Epub 2016 Apr 02. PMID: 27672230; PMCID: PMC5034878.
Copy Download .nbib Format: NLM
GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass.

Endocrinology, diabetes & metabolism case reports

Guimarães M, Rodrigues P, Pereira SS, Nora M, Gonçalves G, Albrechtsen NW, Hartmann B, Holst JJ, Monteiro MP.
PMID: 26266036
Endocrinol Diabetes Metab Case Rep. 2015;2015:150049. doi: 10.1530/EDM-15-0049. Epub 2015 Jul 15.

UNLABELLED: Post-prandial hypoglycemia is frequently found after bariatric surgery. Although rare, pancreatic neuroendocrine tumors (pNET), which occasionally are mixed hormone secreting, can lead to atypical clinical manifestations, including reactive hypoglycemia. Two years after gastric bypass surgery for the treatment...

Cite
Guimarães M, Rodrigues P, Pereira SS, et al. GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass. Endocrinol Diabetes Metab Case Rep. 2015;2015:150049doi: 10.1530/EDM-15-0049.
Guimarães, M., Rodrigues, P., Pereira, S. S., Nora, M., Gonçalves, G., Albrechtsen, N. W., Hartmann, B., Holst, J. J., & Monteiro, M. P. (2015). GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass. Endocrinology, diabetes & metabolism case reports, 2015150049. https://doi.org/10.1530/EDM-15-0049
Guimarães, Marta, et al. "GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass." Endocrinology, diabetes & metabolism case reports vol. 2015 (2015): 150049. doi: https://doi.org/10.1530/EDM-15-0049
Guimarães M, Rodrigues P, Pereira SS, Nora M, Gonçalves G, Albrechtsen NW, Hartmann B, Holst JJ, Monteiro MP. GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass. Endocrinol Diabetes Metab Case Rep. 2015;2015:150049. doi: 10.1530/EDM-15-0049. Epub 2015 Jul 15. PMID: 26266036; PMCID: PMC4530374.
Copy Download .nbib Format: NLM
On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes.

Endocrine connections

Sonne DP, Lund A, Faber J, Holst JJ, Vilsbøll T, Knop FK.
PMID: 25277744
Endocr Connect. 2014 Dec;3(4):193-9. doi: 10.1530/EC-14-0088. Epub 2014 Oct 02.

Bile acids are possible candidate agents in newly identified pathways through which energy expenditure may be regulated. Preclinical studies suggest that bile acids activate the enzyme type 2 iodothyronine deiodinase, which deiodinates thyroxine (T4) to the biologically active triiodothyronine...

Cite
Sonne DP, Lund A, Faber J, et al. On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes. Endocr Connect. 2014;3(4):193-9doi: 10.1530/EC-14-0088.
Sonne, D. P., Lund, A., Faber, J., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2014). On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes. Endocrine connections, 3(4), 193-9. https://doi.org/10.1530/EC-14-0088
Sonne, David P, et al. "On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes." Endocrine connections vol. 3,4 (2014): 193-9. doi: https://doi.org/10.1530/EC-14-0088
Sonne DP, Lund A, Faber J, Holst JJ, Vilsbøll T, Knop FK. On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes. Endocr Connect. 2014 Dec;3(4):193-9. doi: 10.1530/EC-14-0088. Epub 2014 Oct 02. PMID: 25277744; PMCID: PMC4201783.
Copy Download .nbib Format: NLM
Stability of glucagon-like peptide 1 and glucagon in human plasma.

Endocrine connections

Wewer Albrechtsen NJ, Bak MJ, Hartmann B, Christensen LW, Kuhre RE, Deacon CF, Holst JJ.
PMID: 25596009
Endocr Connect. 2015 Mar;4(1):50-7. doi: 10.1530/EC-14-0126. Epub 2015 Jan 16.

To investigate the stability of glucagon-like peptide 1 (GLP-1) and glucagon in plasma under short- and long-term storage conditions. Pooled human plasma (n=20), to which a dipeptidyl peptidase 4 (DPP4) inhibitor and aprotinin were added, was spiked with synthetic...

Cite
Wewer Albrechtsen NJ, Bak MJ, Hartmann B, et al. Stability of glucagon-like peptide 1 and glucagon in human plasma. Endocr Connect. 2015;4(1):50-7doi: 10.1530/EC-14-0126.
Wewer Albrechtsen, N. J., Bak, M. J., Hartmann, B., Christensen, L. W., Kuhre, R. E., Deacon, C. F., & Holst, J. J. (2015). Stability of glucagon-like peptide 1 and glucagon in human plasma. Endocrine connections, 4(1), 50-7. https://doi.org/10.1530/EC-14-0126
Wewer Albrechtsen, Nicolai J, et al. "Stability of glucagon-like peptide 1 and glucagon in human plasma." Endocrine connections vol. 4,1 (2015): 50-7. doi: https://doi.org/10.1530/EC-14-0126
Wewer Albrechtsen NJ, Bak MJ, Hartmann B, Christensen LW, Kuhre RE, Deacon CF, Holst JJ. Stability of glucagon-like peptide 1 and glucagon in human plasma. Endocr Connect. 2015 Mar;4(1):50-7. doi: 10.1530/EC-14-0126. Epub 2015 Jan 16. PMID: 25596009; PMCID: PMC4317691.
Copy Download .nbib Format: NLM
Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males.

Endocrine connections

Skov J, Holst JJ, Gøtze JP, Frøkiær J, Christiansen JS.
PMID: 24327600
Endocr Connect. 2014 Jan 21;3(1):11-6. doi: 10.1530/EC-13-0087. Print 2014.

The antihypertensive actions of glucagon-like peptide-1 (GLP1) receptor agonists have been linked to the release of atrial natriuretic peptide (ANP) in mice. Whether a GLP1-ANP axis exists in humans is unknown. In this study, we examined 12 healthy young...

Cite
Skov J, Holst JJ, Gøtze JP, et al. Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males. Endocr Connect. 2014;3(1):11-6doi: 10.1530/EC-13-0087.
Skov, J., Holst, J. J., Gøtze, J. P., Frøkiær, J., & Christiansen, J. S. (2014). Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males. Endocrine connections, 3(1), 11-6. https://doi.org/10.1530/EC-13-0087
Skov, Jeppe, et al. "Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males." Endocrine connections vol. 3,1 (2014): 11-6. doi: https://doi.org/10.1530/EC-13-0087
Skov J, Holst JJ, Gøtze JP, Frøkiær J, Christiansen JS. Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males. Endocr Connect. 2014 Jan 21;3(1):11-6. doi: 10.1530/EC-13-0087. Print 2014. PMID: 24327600; PMCID: PMC3899585.
Copy Download .nbib Format: NLM
L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia.

American journal of cancer research

Wang Q, Holst J.
PMID: 26101697
Am J Cancer Res. 2015 Mar 15;5(4):1281-94. eCollection 2015.

The L-type amino acid transporter (LAT) family are Na(+)-independent transporters, which deliver neutral amino acids into cells. The four LATs, LAT1 (SLC7A5), LAT2 (SLC7A8), LAT3 (SLC43A1) and LAT4 (SLC43A2), are responsible for the majority of cellular leucine uptake. They...

Cite
Wang Q, Holst J. L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia. Am J Cancer Res. 2015;5(4):1281-94
Wang, Q., & Holst, J. (2015). L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia. American journal of cancer research, 5(4), 1281-94.
Wang, Qian, and Holst, Jeff. "L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia." American journal of cancer research vol. 5,4 (2015): 1281-94.
Wang Q, Holst J. L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia. Am J Cancer Res. 2015 Mar 15;5(4):1281-94. eCollection 2015. PMID: 26101697; PMCID: PMC4473310.
Copy Download .nbib Format: NLM
Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome.

Endocrine connections

Glintborg D, Mumm H, Holst JJ, Andersen M.
PMID: 28432082
Endocr Connect. 2017 May;6(4):267-277. doi: 10.1530/EC-17-0034. Epub 2017 Apr 21.

CONTEXT: Insulin resistance in polycystic ovary syndrome (PCOS) may increase the risk of reactive hypoglycaemia (RH) and decrease glucagon-like peptide-1 (GLP-1) secretion. The possible effects of treatment with oral contraceptives (OCP) and/or metformin on GLP-1 secretion and risk of...

Cite
Glintborg D, Mumm H, Holst JJ, et al. Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome. Endocr Connect. 2017;6(4):267-277doi: 10.1530/EC-17-0034.
Glintborg, D., Mumm, H., Holst, J. J., & Andersen, M. (2017). Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome. Endocrine connections, 6(4), 267-277. https://doi.org/10.1530/EC-17-0034
Glintborg, Dorte, et al. "Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome." Endocrine connections vol. 6,4 (2017): 267-277. doi: https://doi.org/10.1530/EC-17-0034
Glintborg D, Mumm H, Holst JJ, Andersen M. Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome. Endocr Connect. 2017 May;6(4):267-277. doi: 10.1530/EC-17-0034. Epub 2017 Apr 21. PMID: 28432082; PMCID: PMC5457494.
Copy Download .nbib Format: NLM
Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer.

ACS medicinal chemistry letters

Balog A, Rampulla R, Martin GS, Krystek SR, Attar R, Dell-John J, DiMarco JD, Fairfax D, Gougoutas J, Holst CL, Nation A, Rizzo C, Rossiter LM, Schweizer L, Shan W, Spergel S, Spires T, Cornelius G, Gottardis M, Trainor G, Vite GD, Salvati ME.
PMID: 26288692
ACS Med Chem Lett. 2015 Jun 19;6(8):908-12. doi: 10.1021/acsmedchemlett.5b00173. eCollection 2015 Aug 13.

BMS-641988 (23) is a novel, nonsteroidal androgen receptor antagonist designed for the treatment of prostate cancer. The compound has high binding affinity for the AR and acts as a functional antagonist in vitro. BMS-641988 is efficacious in multiple human...

Cite
Balog A, Rampulla R, Martin GS, et al. Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer. ACS Med Chem Lett. 2015;6(8):908-12doi: 10.1021/acsmedchemlett.5b00173.
Balog, A., Rampulla, R., Martin, G. S., Krystek, S. R., Attar, R., Dell-John, J., DiMarco, J. D., Fairfax, D., Gougoutas, J., Holst, C. L., Nation, A., Rizzo, C., Rossiter, L. M., Schweizer, L., Shan, W., Spergel, S., Spires, T., Cornelius, G., Gottardis, M., Trainor, G., Vite, G. D., & Salvati, M. E. (2015). Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer. ACS medicinal chemistry letters, 6(8), 908-12. https://doi.org/10.1021/acsmedchemlett.5b00173
Balog, Aaron, et al. "Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer." ACS medicinal chemistry letters vol. 6,8 (2015): 908-12. doi: https://doi.org/10.1021/acsmedchemlett.5b00173
Balog A, Rampulla R, Martin GS, Krystek SR, Attar R, Dell-John J, DiMarco JD, Fairfax D, Gougoutas J, Holst CL, Nation A, Rizzo C, Rossiter LM, Schweizer L, Shan W, Spergel S, Spires T, Cornelius G, Gottardis M, Trainor G, Vite GD, Salvati ME. Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer. ACS Med Chem Lett. 2015 Jun 19;6(8):908-12. doi: 10.1021/acsmedchemlett.5b00173. eCollection 2015 Aug 13. PMID: 26288692; PMCID: PMC4538445.
Copy Download .nbib Format: NLM
Giant Zn14 molecular building block in hydrogen-bonded network with permanent porosity for gas uptake.

Journal of the American Chemical Society

Mondal SS, Bhunia A, Kelling A, Schilde U, Janiak C, Holdt HJ.
PMID: 24313724
J Am Chem Soc. 2014 Jan 08;136(1):44-7. doi: 10.1021/ja410595q. Epub 2013 Dec 16.

In situ imidazolate-4,5-diamide-2-olate linker generation leads to the formation of a [Zn14(L2)12(O)(OH)2(H2O)4] molecular building block (MBB) with a Zn6 octahedron inscribed in a Zn8 cube. The MBBs connect by amide-amide hydrogen bonds to a 3D robust supramolecular network which...

Cite
Mondal SS, Bhunia A, Kelling A, et al. Giant Zn14 molecular building block in hydrogen-bonded network with permanent porosity for gas uptake. J Am Chem Soc. 2013;136(1):44-7doi: 10.1021/ja410595q.
Mondal, S. S., Bhunia, A., Kelling, A., Schilde, U., Janiak, C., & Holdt, H. J. (2014). Giant Zn14 molecular building block in hydrogen-bonded network with permanent porosity for gas uptake. Journal of the American Chemical Society, 136(1), 44-7. https://doi.org/10.1021/ja410595q
Mondal, Suvendu Sekhar, et al. "Giant Zn14 molecular building block in hydrogen-bonded network with permanent porosity for gas uptake." Journal of the American Chemical Society vol. 136,1 (2014): 44-7. doi: https://doi.org/10.1021/ja410595q
Mondal SS, Bhunia A, Kelling A, Schilde U, Janiak C, Holdt HJ. Giant Zn14 molecular building block in hydrogen-bonded network with permanent porosity for gas uptake. J Am Chem Soc. 2014 Jan 08;136(1):44-7. doi: 10.1021/ja410595q. Epub 2013 Dec 16. PMID: 24313724.
Copy Download .nbib Format: NLM
Glucagon-like peptide-1: a basis for new approaches to the management of diabetes.

Drugs of today (Barcelona, Spain : 1998)

Deacon CF, Holst JJ, Carr RD.
PMID: 12973381
Drugs Today (Barc). 1999 Mar;35(3):159-70. doi: 10.1358/dot.1999.35.3.533845.

Type 2 diabetes mellitus is a metabolic disease resulting in raised blood sugar which, if not satisfactorily controlled, can cause severe and often debilitating complications. Unfortunately, for many patients, the existing therapies do not give adequate control. Glucagon-like peptide-1...

Cite
Deacon CF, Holst JJ, Carr RD. Glucagon-like peptide-1: a basis for new approaches to the management of diabetes. Drugs Today (Barc). 1999;35(3):159-70doi: 10.1358/dot.1999.35.3.533845.
Deacon, C. F., Holst, J. J., & Carr, R. D. (1999). Glucagon-like peptide-1: a basis for new approaches to the management of diabetes. Drugs of today (Barcelona, Spain : 1998), 35(3), 159-70. https://doi.org/10.1358/dot.1999.35.3.533845
Deacon, C F, et al. "Glucagon-like peptide-1: a basis for new approaches to the management of diabetes." Drugs of today (Barcelona, Spain : 1998) vol. 35,3 (1999): 159-70. doi: https://doi.org/10.1358/dot.1999.35.3.533845
Deacon CF, Holst JJ, Carr RD. Glucagon-like peptide-1: a basis for new approaches to the management of diabetes. Drugs Today (Barc). 1999 Mar;35(3):159-70. doi: 10.1358/dot.1999.35.3.533845. PMID: 12973381.
Copy Download .nbib Format: NLM
Conformational analysis of mixed oxathia crown ethers and their complexational ability towards Ag(I) and Pd(II)-an experimental solution NMR and theoretical molecular modelling study.

Organic & biomolecular chemistry

Holzberger A, Holdt HJ, Kleinpeter E.
PMID: 15188035
Org Biomol Chem. 2004 Jun 21;2(12):1691-7. doi: 10.1039/b402224f. Epub 2004 May 19.

Both the conformation and flexibility of four mixed oxathia crown ethers and their Ag(I) and Pd(II) complexes were studied by (1)H NMR (delta, J, NOE, T(1)), (13)C NMR, dynamic (1)H NMR spectroscopy and molecular modelling. The stoichiometry and stability...

Cite
Holzberger A, Holdt HJ, Kleinpeter E. Conformational analysis of mixed oxathia crown ethers and their complexational ability towards Ag(I) and Pd(II)-an experimental solution NMR and theoretical molecular modelling study. Org Biomol Chem. 2004;2(12):1691-7doi: 10.1039/b402224f.
Holzberger, A., Holdt, H. J., & Kleinpeter, E. (2004). Conformational analysis of mixed oxathia crown ethers and their complexational ability towards Ag(I) and Pd(II)-an experimental solution NMR and theoretical molecular modelling study. Organic & biomolecular chemistry, 2(12), 1691-7. https://doi.org/10.1039/b402224f
Holzberger, Anja, et al. "Conformational analysis of mixed oxathia crown ethers and their complexational ability towards Ag(I) and Pd(II)-an experimental solution NMR and theoretical molecular modelling study." Organic & biomolecular chemistry vol. 2,12 (2004): 1691-7. doi: https://doi.org/10.1039/b402224f
Holzberger A, Holdt HJ, Kleinpeter E. Conformational analysis of mixed oxathia crown ethers and their complexational ability towards Ag(I) and Pd(II)-an experimental solution NMR and theoretical molecular modelling study. Org Biomol Chem. 2004 Jun 21;2(12):1691-7. doi: 10.1039/b402224f. Epub 2004 May 19. PMID: 15188035.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 307 entries